๎
๎ผ
๎
Repligen Corp
RGEN160.591USD
+3.201+2.03%
์์ฅ ์ด์ ์๊ฐย ๏ผET๏ผ์์ธ๋ 15๋ถ ์ง์ฐ๋ฉ๋๋ค
9.04B์๊ฐ์ด์ก
5755.96P/E TTM
๎
์์ธํ ๋ด์ฉ์ Repligen Corp ํ์ฌ
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Its filtration products are used in process development and process scale (clinical and commercial) production. Its XCell ATF systems are used in upstream perfusion (continuous) and N-1 (intensified fed-batch or hybrid perfusion) cell culture processing. Its chromatography franchise includes several products used in downstream purification, development, manufacturing and quality control of biological drugs. Its process analytics products complement and support its filtration, chromatography and protein franchises. Its TangenX product portfolio includes flat sheet (FS) tangential flow filtration (TFF) cassettes used primarily in downstream and ultrafiltration processes. Its desktop portfolio includes MAVERICK and MAVEN, REBEL, and ZipChip.
Repligen Corp ์ ๋ณด
๎์ข
๋ชฉ ์ฝ๋ RGEN
ํ์ฌ ์ด๋ฆRepligen Corp
์์ฅ์ผApr 29, 1986
CEOLoeillot (Olivier)
์ง์ ์1778
์ ํOrdinary Share
ํ๊ณ ์ฐ๋ ์ข
๋ฃApr 29
์ฃผ์Building 1, Suite 100
๋์WALTHAM
์ฆ๊ถ ๊ฑฐ๋์NASDAQ OMX - NASDAQ BASIC
๊ตญ๊ฐUnited States of America
์ฐํธ ๋ฒํธ02453
์ ํ17814499560
์น์ฌ์ดํธhttps://www.repligen.com/
์ข
๋ชฉ ์ฝ๋ RGEN
์์ฅ์ผApr 29, 1986
CEOLoeillot (Olivier)
Repligen Corp์ ํ์ฌ ์์์ง
๎์ด๋ฆ
์ด๋ฆ/์ง์
์ง์
์ฃผ์ ๋ณด์
๋ณ๋
Ms. Karen A. Dawes
Ms. Karen A. Dawes
Lead Independent Director
Lead Independent Director
91.29K
+1.08%
Mr. Glenn P. Muir
Mr. Glenn P. Muir
Independent Director
Independent Director
32.55K
+3.08%
Mr. Ralf Kuriyel
Mr. Ralf Kuriyel
Senior Vice President - Research and Development
Senior Vice President - Research and Development
12.56K
+147.18%
Mr. Olivier Loeillot
Mr. Olivier Loeillot
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
6.02K
-53.90%
Mr. Nicolas M. Barthelemy
Mr. Nicolas M. Barthelemy
Independent Director
Independent Director
4.94K
+24.53%
Mr. Rohin Mhatre, Ph.D.
Mr. Rohin Mhatre, Ph.D.
Independent Director
Independent Director
3.32K
+41.49%
Dr. Konstantin Konstantinov, Ph.D.
Dr. Konstantin Konstantinov, Ph.D.
Independent Director
Independent Director
--
--
Mr. Jason K. Garland
Mr. Jason K. Garland
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Tony John Hunt
Mr. Tony John Hunt
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Dr. Martin D. Madaus, Ph.D.
Dr. Martin D. Madaus, Ph.D.
Independent Director
Independent Director
--
--
๋ ๋ณด๊ธฐ
์ด๋ฆ
์ด๋ฆ/์ง์
์ง์
์ฃผ์ ๋ณด์
๋ณ๋
Ms. Karen A. Dawes
Ms. Karen A. Dawes
Lead Independent Director
Lead Independent Director
91.29K
+1.08%
Mr. Glenn P. Muir
Mr. Glenn P. Muir
Independent Director
Independent Director
32.55K
+3.08%
Mr. Ralf Kuriyel
Mr. Ralf Kuriyel
Senior Vice President - Research and Development
Senior Vice President - Research and Development
12.56K
+147.18%
Mr. Olivier Loeillot
Mr. Olivier Loeillot
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
6.02K
-53.90%
Mr. Nicolas M. Barthelemy
Mr. Nicolas M. Barthelemy
Independent Director
Independent Director
4.94K
+24.53%
Mr. Rohin Mhatre, Ph.D.
Mr. Rohin Mhatre, Ph.D.
Independent Director
Independent Director
3.32K
+41.49%
์์ต ๋ถ์
ํตํ: USD๋ง์ง๋ง ์
๋ฐ์ดํธ: Mon, Oct 6
ํตํ: USD๋ง์ง๋ง ์
๋ฐ์ดํธ: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
๊ธฐ์
์ด ์์ง ๊ด๋ จ ๋ฐ์ดํฐ๋ฅผ ๊ณต๊ฐํ์ง ์์์ต๋๋ค.
์ง์ญ๋ณUSD
์ด๋ฆ
์์ต
๋น์จ
North America
89.36M
49.00%
Europe
69.30M
38.00%
APAC/Other
23.71M
13.00%
์ฌ์
๋ณ
์ง์ญ๋ณ
๊ธฐ์
์ด ์์ง ๊ด๋ จ ๋ฐ์ดํฐ๋ฅผ ๊ณต๊ฐํ์ง ์์์ต๋๋ค.
์ฃผ์ ๋ณด์ ํต๊ณ
๋ง์ง๋ง ์
๋ฐ์ดํธ: Mon, Dec 8
๋ง์ง๋ง ์
๋ฐ์ดํธ: Mon, Dec 8
์ฃผ์ฃผ
์ฃผ์ฃผ ์ ํ
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น์จ
The Vanguard Group, Inc.
8.94%
BlackRock Institutional Trust Company, N.A.
8.24%
T. Rowe Price Associates, Inc.
6.14%
Roy T. Eddleman UEO
5.88%
United Capital Financial Advisors, LLC
4.90%
๊ธฐํ
65.91%
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น์จ
The Vanguard Group, Inc.
8.94%
BlackRock Institutional Trust Company, N.A.
8.24%
T. Rowe Price Associates, Inc.
6.14%
Roy T. Eddleman UEO
5.88%
United Capital Financial Advisors, LLC
4.90%
๊ธฐํ
65.91%
์ฃผ์ฃผ ์ ํ
์ฃผ์ฃผ
๋น์จ
Investment Advisor
59.79%
Investment Advisor/Hedge Fund
29.04%
Hedge Fund
15.73%
Individual Investor
6.33%
Research Firm
2.20%
Pension Fund
2.00%
Bank and Trust
0.71%
Sovereign Wealth Fund
0.60%
Family Office
0.50%
๊ธฐ๊ด ์ฃผ์ ๋ณด์
๎๋ง์ง๋ง ์
๋ฐ์ดํธ: Wed, Oct 1
๋ง์ง๋ง ์
๋ฐ์ดํธ: Wed, Oct 1
๋ณด๊ณ ๊ธฐ๊ฐ
๊ธฐ๊ด ์
๋ณด์ ์ฃผ์
๋น์จ
๋ณ๋
2025Q3
1027
55.23M
98.12%
-6.26M
2025Q2
1028
61.98M
110.32%
-3.21M
2025Q1
1054
62.91M
111.98%
-2.72M
2024Q4
1054
61.13M
109.11%
-3.76M
2024Q3
1046
60.75M
108.48%
-6.10M
2024Q2
1039
61.28M
109.67%
-2.73M
2024Q1
1036
60.56M
108.45%
-5.41M
2023Q4
1062
62.13M
111.29%
-2.30M
2023Q3
1063
61.47M
110.27%
+2.91M
2023Q2
1050
59.01M
105.99%
+1.34M
๋ ๋ณด๊ธฐ
์ฃผ์ฃผ ํ๋
๎์ด๋ฆ
๋ณด์ ์ฃผ์
๋น์จ
๋ณ๋
Chg %
๋ ์ง
The Vanguard Group, Inc.
5.07M
9%
-2.87K
-0.06%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
4.71M
8.37%
-180.36K
-3.69%
Jun 30, 2025
T. Rowe Price Associates, Inc.
3.43M
6.1%
-3.13M
-47.69%
Aug 31, 2025
Roy T. Eddleman UEO
3.31M
5.89%
-67.50K
-2.00%
Dec 31, 2024
Fidelity Management & Research Company LLC
1.36M
2.43%
+842.96K
+161.67%
Jun 30, 2025
State Street Investment Management (US)
1.62M
2.88%
-66.31K
-3.93%
Jun 30, 2025
Citadel Advisors LLC
1.06M
1.89%
-266.68K
-20.06%
Jun 30, 2025
Point72 Asset Management, L.P.
1.91M
3.4%
+796.75K
+71.36%
Jun 30, 2025
Holocene Advisors, LP
936.81K
1.67%
-23.17K
-2.41%
Jun 30, 2025
๋ ๋ณด๊ธฐ
๊ด๋ จ ETF
๎๋ง์ง๋ง ์
๋ฐ์ดํธ: Sat, Dec 6
๋ง์ง๋ง ์
๋ฐ์ดํธ: Sat, Dec 6
์ด๋ฆ
๋น์จ
First Trust NYSE Arca Biotechnology Index Fund
3.45%
Alger Mid Cap 40 ETF
3.1%
Congress SMid Growth ETF
2.46%
iShares Health Innovation Active ETF
2.28%
VanEck Biotech ETF
1.34%
Franklin Genomic Advancements ETF
1.23%
Pacer US Export Leaders ETF
1.18%
Alger 35 ETF
1.15%
WisdomTree BioRevolution Fund
1.06%
iShares Biotechnology ETF
0.7%
๋ ๋ณด๊ธฐ
First Trust NYSE Arca Biotechnology Index Fund
๋น์จ3.45%
Alger Mid Cap 40 ETF
๋น์จ3.1%
Congress SMid Growth ETF
๋น์จ2.46%
iShares Health Innovation Active ETF
๋น์จ2.28%
VanEck Biotech ETF
๋น์จ1.34%
Franklin Genomic Advancements ETF
๋น์จ1.23%
Pacer US Export Leaders ETF
๋น์จ1.18%
Alger 35 ETF
๋น์จ1.15%
WisdomTree BioRevolution Fund
๋น์จ1.06%
iShares Biotechnology ETF
๋น์จ0.7%
์ฃผ์ ๋ฐฐ๋น๊ธ
๎์ง๋ 5๋
๋์ ์ด
0.00
USD์ ๋ฐฐ๋น๊ธ์ด ๋ถ๋ฐฐ๋์์ต๋๋ค.
๋ ์ง
๋ฐฐ๋น๊ธ
๊ธฐ์ค์ผ
์ง๊ธ์ผ
๋ฐฐ๋น๋ฝ์ผ
๋ฐ์ดํฐ ์์
์ฃผ์ ๋ถํ
๎๋ ์ง
์ ํ
๋น์จ
๋ฐ์ดํฐ ์์
๋ ์ง
์ ํ
๋น์จ
๋ฐ์ดํฐ ์์
์์ฃผ ๋ฌป๋ ์ง๋ฌธ
Repligen Corp์ ์์ 5๋ ์ฃผ์ฃผ๋ ๋๊ตฌ์ธ๊ฐ์?
๎Repligen Corp์ ์์ 5๋ ์ฃผ์ฃผ๋ ๋ค์๊ณผ ๊ฐ์ต๋๋ค:
The Vanguard Group, Inc.๋ 5.07M์ฃผ์ ์ฃผ์์ ๋ณด์ ํ๊ณ ์์ผ๋ฉฐ, ์ ์ฒด ์ฃผ์์ 9.00%๋ฅผ ์ฐจ์งํฉ๋๋ค.
BlackRock Institutional Trust Company, N.A.๋ 4.71M์ฃผ์ ์ฃผ์์ ๋ณด์ ํ๊ณ ์์ผ๋ฉฐ, ์ ์ฒด ์ฃผ์์ 8.37%๋ฅผ ์ฐจ์งํฉ๋๋ค.
T. Rowe Price Associates, Inc.๋ 3.43M์ฃผ์ ์ฃผ์์ ๋ณด์ ํ๊ณ ์์ผ๋ฉฐ, ์ ์ฒด ์ฃผ์์ 6.10%๋ฅผ ์ฐจ์งํฉ๋๋ค.
Roy T. Eddleman UEO๋ 3.31M์ฃผ์ ์ฃผ์์ ๋ณด์ ํ๊ณ ์์ผ๋ฉฐ, ์ ์ฒด ์ฃผ์์ 5.89%๋ฅผ ์ฐจ์งํฉ๋๋ค.
Fidelity Management & Research Company LLC๋ 1.36M์ฃผ์ ์ฃผ์์ ๋ณด์ ํ๊ณ ์์ผ๋ฉฐ, ์ ์ฒด ์ฃผ์์ 2.43%๋ฅผ ์ฐจ์งํฉ๋๋ค.
The Vanguard Group, Inc.๋ 5.07M์ฃผ์ ์ฃผ์์ ๋ณด์ ํ๊ณ ์์ผ๋ฉฐ, ์ ์ฒด ์ฃผ์์ 9.00%๋ฅผ ์ฐจ์งํฉ๋๋ค.
BlackRock Institutional Trust Company, N.A.๋ 4.71M์ฃผ์ ์ฃผ์์ ๋ณด์ ํ๊ณ ์์ผ๋ฉฐ, ์ ์ฒด ์ฃผ์์ 8.37%๋ฅผ ์ฐจ์งํฉ๋๋ค.
T. Rowe Price Associates, Inc.๋ 3.43M์ฃผ์ ์ฃผ์์ ๋ณด์ ํ๊ณ ์์ผ๋ฉฐ, ์ ์ฒด ์ฃผ์์ 6.10%๋ฅผ ์ฐจ์งํฉ๋๋ค.
Roy T. Eddleman UEO๋ 3.31M์ฃผ์ ์ฃผ์์ ๋ณด์ ํ๊ณ ์์ผ๋ฉฐ, ์ ์ฒด ์ฃผ์์ 5.89%๋ฅผ ์ฐจ์งํฉ๋๋ค.
Fidelity Management & Research Company LLC๋ 1.36M์ฃผ์ ์ฃผ์์ ๋ณด์ ํ๊ณ ์์ผ๋ฉฐ, ์ ์ฒด ์ฃผ์์ 2.43%๋ฅผ ์ฐจ์งํฉ๋๋ค.
Repligen Corp์ ์์ 3๋ ์ฃผ์ฃผ ์ ํ์ ๋ฌด์์ธ๊ฐ์?
๎Repligen Corp์ ์ฃผ์ ์ฃผ์ฃผ ์ ํ ์์ 3๊ฐ์ง๋
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
T. Rowe Price Associates, Inc.์ ๋๋ค.
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
T. Rowe Price Associates, Inc.์ ๋๋ค.
Repligen Corp(RGEN)์ ์ฃผ์์ ๋ณด์ ํ ๊ธฐ๊ด์ ๋ช ๊ฐ์ ๋๊น?
๎2025Q3 ๊ธฐ์ค์ผ๋ก, Repligen Corp์ ์ฃผ์์ ๋ณด์ ํ ๊ธฐ๊ด์ ์ด 1027๊ณณ์ด๋ฉฐ, ์ด๋ค์ด ๋ณด์ ํ ์ฃผ์์ ์ด ๊ฐ์น๋ ์ฝ 55.23M๋ก ์ ์ฒด ๋ฐํ ์ฃผ์์ 98.12%๋ฅผ ์ฐจ์งํฉ๋๋ค. ์ด๋ 2025Q2 ๋๋น -12.20% ์ฆ๊ฐํ ์์น์
๋๋ค.
Repligen Corp์ ์ต๋ ์์ต์์ ๋ฌด์์ธ๊ฐ์?
๎FY2025Q2 ๊ธฐ์ค, Repligen Corp์ -- ๋ถ๋ฌธ์ด ๊ฐ์ฅ ๋์ ๋งค์ถ์ ๊ธฐ๋กํ์ผ๋ฉฐ, ๊ธ์ก์ --๋ก ์ ์ฒด ๋งค์ถ์ --%๋ฅผ ์ฐจ์งํ์ต๋๋ค.
